NEXGEN COMPLETE KNEE SOLUTION POLY PATELLA 5972-65-32

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-04-22 for NEXGEN COMPLETE KNEE SOLUTION POLY PATELLA 5972-65-32 manufactured by Zimmer.

Event Text Entries

[16852898] I have had gentamicin-induced vestibulopathy - bilateral vestibular hypofunction - moderate to severe since 1991 documented in my 1993 us (b)(6)medical board. This allergy/sensitivity/toxicity was known by dr. (b)(6), (b)(4) med ctr, (b)(6), as part of the (b)(6) program. Some 1000mg of gentamycin was put in the bone cement implant of a r total knee arthroplasty plus 2000mg iv of vancomycin. Both ototoxic. I was told by dr. (b)(6) that he would "substitute keflex" which he did not do. I have become increasingly symptomatic since and now have "severe bilateral vestibular hypofunction" and a high frequency hearing loss. At present, the (b)(6) is trying to determine whether or not the implants should be removed and revised. Would there be less damage with a one-time bolus of gentamicin when the implants are removed vs. Slow elution of tiny amounts of gentamycin released on a daily basis. What studies do the fda have to answer this question? Please advise. Dr. (b)(6), (b)(6) med ctr performed a tka (replacement) of r knee ignoring my history of gentamicin toxicity which was told to him prior to surgery. Told he would "substitute keflex" in the bone cement mix. Did not do so. Implants continue to elute (leach) small amounts of gentamycin for up to 25 years. Staff failed to adhere to contraindications of use of gentamycin given previous history of known allergy/sensitivity/toxicity.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5042278
MDR Report Key4729800
Date Received2015-04-22
Date of Report2015-04-15
Date of Event2013-07-08
Date Added to Maude2015-04-28
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationPATIENT
Health Professional0
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Sequence Number: 1

Brand NameNEXGEN COMPLETE KNEE SOLUTION POLY PATELLA
Generic NameKNEE REPLACEMENT
Product CodeHTG
Date Received2015-04-22
Catalog Number5972-65-32
Lot Number62394734
Device Sequence No1
Device Event Key0
ManufacturerZIMMER

Device Sequence Number: 2

Brand NameTIBIAL TRAY
Generic NameTIBIAL
Product CodeHSH
Date Received2015-04-22
Catalog Number00-5954-037-02
Lot Number621066003
Device Sequence No2
Device Event Key0
ManufacturerZIMMER

Device Sequence Number: 3

Brand NameCRUCIATE RETRAINING FEMORAL COMPONENT
Generic NameFEMORAL COMPONENT
Product CodeJWH
Date Received2015-04-22
Catalog Number5952-15-06
Lot Number62318594
Device Sequence No3
Device Event Key0
ManufacturerZIMMER

Device Sequence Number: 4

Brand NameARTICULAR SURFACE
Generic NameARTICULAR SURFACE
Product CodeJWH
Date Received2015-04-22
Catalog Number5952-30-10
Lot Number62280599
Device Expiration Date2018-07-01
Device Sequence No4
Device Event Key0
ManufacturerZIMMER

Device Sequence Number: 5

Brand NameCANCELLOUS SCREWS
Generic NameSCREW
Product CodeHWC
Date Received2015-04-22
Catalog NumberUNK
Lot NumberUNK
Device Sequence No5
Device Event Key0
ManufacturerZIMMER

Device Sequence Number: 6

Brand NameBONE CEMENT WITH GENTAMICN
Generic NameBONE CEMENT
Product CodeLOD
Date Received2015-04-22
Catalog Number00-1113-140-01
Lot Number75434316
Device Expiration Date2016-07-01
Device Sequence No6
Device Event Key0
ManufacturerZIMMER

Device Sequence Number: 7

Brand NameBONE CEMENT WITH GENTAMICIN
Generic NameBONE CEMENT
Product CodeLOD
Date Received2015-04-22
Catalog Number00-1113-140-01
Lot Number76414339
Device Expiration Date2017-01-01
Device Sequence No7
Device Event Key0
ManufacturerZIMMER


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2015-04-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.